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Intrinsic binding enthalpyCytidine monophosphate kinase fromMycobacterium tuberculosis (MtCMK) likely plays a role in supplying
precursors for nucleic acid synthesis. MtCMK catalyzes the ATP-dependent phosphoryl group transfer
preferentially to CMP and dCMP. Initial velocity studies and Isothermal titration calorimetry (ITC)
measurements showed that MtCMK follows a random-order mechanism of substrate (CMP and ATP)
binding, and an ordered mechanism for product release, in which ADP is released ﬁrst followed by
CDP. The thermodynamic signatures of CMP and CDP binding to MtCMK showed favorable enthalpy
and unfavorable entropy, and ATP binding was characterized by favorable changes in enthalpy and
entropy. The contribution of linked protonation events to the energetics of MtCMK:phosphoryl group
acceptor binary complex formation suggested a net gain of protons. Values for the pKa of a likely chemical
group involved in proton exchange and for the intrinsic binding enthalpy were calculated. The Asp187
side chain of MtCMK is suggested as the likely candidate for the protonation event. Data on
thermodynamics of binary complex formation were collected to evaluate the contribution of 20-OH group
to intermolecular interactions. The data are discussed in light of functional and structural comparisons
between CMP/dCMP kinases and UMP/CMP ones.
 2013 Elsevier Inc. All rights reserved.Introduction need for alternative therapeutic chemical entities to both shortenHuman tuberculosis (TB)2, caused mainly by Mycobacterium
tuberculosis, remains one of the most critical problems for global
health control, reaching over 1.4 million deaths in 2010 [1–3]. TB
‘‘short-course’’ therapy consists of 2 months of treatment with rif-
ampicin, isoniazid, ethambutol and pyrazinamide, followed by
4 months of treatment with isoniazid and rifampicin [3]. However,
noncompliance with TB treatment gives rise to appearance of
drug-resistant strains of M. tuberculosis [4–6], which underlines thethe duration of therapy and combat the problem of clinical drug
resistance. As the cmk-gene product has been predicted to be re-
quired for optimal in vitro growth of M. tuberculosis H37Rv strain
by Himar1-based transposon mutagenesis [7]. More recently, high-
resolution global phenotypic proﬁling results have prompted the
proposal that the cmk-gene product is essential for in vitro growth
in glycerol and cholesterol (a critical carbon source during infection)
media [8]. Accordingly, efforts to understand the mode of action of
the cmk-gene product appear to be worth pursuing to provide a basisail.com
idine 50-
osphate;
PPS, N-2-
PS, 3-(N-
cleoside
mide gel
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activity.
Nucleoside monophosphate (NMP) kinases play pivotal roles in
both de novo synthesis and salvage pathway of DNA and RNA pre-
cursors [9,10]. Bacterial cytidine 50-monophosphate (CMP) kinase
(CMK), which is part of pyrimidine nucleotide interconversion
pathways, catalyzes the c-phosphoryl group transfer from, usually,
adenosine-50-triphosphate (ATP) to either CMP or 20-deoxy-CMP
(dCMP). We have previously reported that cmk gene in M. tubercu-
losis encodes a protein with CMK activity (MtCMK), which catalyzes
the phosphoryl transfer from ATP to dCMP, CMP or uridine
50-monophosphate (UMP) to form the corresponding nucleoside
diphosphates [11]. However,MtCMK preferentially phosphorylates
dCMP and CMP, whereas UMP is a poor substrate [11] (Fig. 1).
The speciﬁcity of MtCMK for dCMP and CMP is not surprising since
it has recently been shown that the Rv2883c locus (pyrH) in M.
tuberculosis codes for a functional uridine 50-monophosphate kinase
(MtUMPK) [12].
Bacterial CMP kinases are regarded as potential drug targets
due to the primary structure divergence and substrate afﬁnity
when compared with the human orthologue UMP/CMP kinase
[13]. In addition, CMK enzymes have been reported to be essential
for different organisms: Streptococcus pneumonia [14], Bacillus sub-
tilis [15], Salmonella typhimurium [16] and, probably,M. tuberculosis
[7,8] due to its proposed role in recycling nucleotides derived from
RNA degradation in the latter [11].
NMP kinases undergo large conformational changes upon bind-
ing of substrates [17]. NMP kinases have an overall well-conserved
fold with three domains [18]: the relatively rigid CORE domain
(containing a ﬁve-stranded parallel b-sheet), the LID domain that
closes the active site upon ATP binding, and the NMP binding do-
main, which closes the active site upon binding of the phosphate
acceptor. NMP kinases are divided into short and long forms. The
latter group consists of adenylate kinases with an insertion of
approximately 27 amino acid residues in the LID domain [13]. Bac-
terial CMKs, includingMtCMK, belongs to a third family of NMP ki-
nases as they possess distinct features: a short LID domain, and an
insertion of 40 amino acid residues in the NMP-binding domain
[18].
In the present work, isothermal titration calorimetry (ITC) stud-
ies were performed to determine the order, if any, of addition of
substrates (CMP and ATP) to and release of products (CDP and
ADP) from MtCMK. Initial velocity studies were also carried out
to evaluate the speciﬁcity of MtCMK for phosphate acceptor using
cytosine-b-D-arabinofuranoside 50-monophosphate (AraCMP) and
20-30-dideoxy-cytidine 50-monophosphate (ddCMP) as substrates.
The number of protons released/taken up upon binary complex
formation betweenMtCMK and either CMP, dCMP or AraCMP were
evaluated using buffers with different enthalpies of ionization. An
estimate for the pKa of a likely chemical group involved in proton
exchange upon binary complex formation was obtained from pH-
dependence of the binding energetics. A linkage between binaryFig. 1. Chemical reaction catalyzed by MtCMK. This enzyme catalyzes the ATP-
dependent phosphoryl group transfer preferentially to CMP and dCMP [11].complex formation and protonation was observed and a value for
the intrinsic enthalpy of binding was determined. Data on thermo-
dynamics of CMP, dCMP and AraCMP binding to MtCMK were col-
lected to evaluate the contribution of 20-OH group to binary
complex formation. The data here presented provide a thermody-
namic evaluation of the role of ionizable groups involved in
MtCMK:CMP, MtCMK:dCMP and MtCMK:AraCMP complex
formation.
Materials and methods
Materials
Chemicals were of analytical or reagent grade and used without
further puriﬁcation. ATP, CMP, cytidine 50-diphosphate (CDP) and
dCMP were purchased from Sigma–Aldrich. AraCMP was obtained
from Santa Cruz Biotechnology and ddCMP from Synﬁne Re-
search. All puriﬁcation steps were carried out using an ÄKTA sys-
tem (GE Healthcare) at 4 C and sample elution was monitored
by UV detection. Protein fractions were analyzed by SDS–PAGE
12% [19]. The steady-state activity assays were performed using
a UV-2550 UV/Visible spectrophotometer (Shimadzu) in 1 cm
pathlength cuvettes and assay mixtures of 500 lL ﬁnal volume.
ITC experiments were carried out using an iTC200 Microcalorime-
ter (MicroCal, Inc., GE Healthcare).
Protein preparation
Electrocompetent BL21(DE3) Escherichia coli cells were trans-
formed with pET-23a(+)::cmk recombinant plasmid, and cell
growth and puriﬁcation steps of MtCMK were as described else-
where [11]. The pooled fractions were dialyzed against 50 mM
Tris–HCl pH 7.5, 50 mM KCl and 5 mM MgCl2, concentrated using
an AMICON (Millipore Corporation, Bedford, MA) ultraﬁltration
membrane (MWCO = 10 kDa), and stored at 80 C. Total protein
concentration was determined by the method of Bradford [20],
using the Bio-Rad protein assay kit (Bio-Rad Laboratories) and bo-
vine serum albumin as standard. As described elsewhere [11], a
typical yield of 5 mg of homogeneous recombinantMtCMK per liter
of cell culture could be obtained.
Enzyme activity assays and determination of steady-state kinetic
parameters
Enzyme activity was routinely measured using CMP and ATP as
substrates and the reaction was started by the addition of recom-
binant MtCMK. All enzyme activity measurements were carried
out at 25 C. The ADP product formation was coupled to chemical
reactions catalyzed by pyruvate kinase (PK; EC 2.7.1.40) and lactate
dehydrogenase (LDH; EC 1.1.1.27), and the decrease in absorbance
at 340 nm (eb-NADH = 6.22  103 M1 cm1) due to NADH oxidation
was monitored as described elsewhere [11,21,22]. The enzyme as-
say mixture contained 40 mM Hepes pH 7.6, 40 mM KCl and 5 mM
MgCl2, 1.5 mM PEP, 0.2 mM NADH, 6 U mL1 PK, and 5 U mL1
LDH. Initial steady-state rates were calculated from the linear por-
tion of the reaction curve under experimental conditions in which
less than 5% of substrate was consumed.
To evaluate further the speciﬁcity for phosphate acceptor, CMP
was replacedwith either AraCMP or ddCMP (nucleosidemonophos-
phate analogs), at varying concentrations, utilizing the coupled
standard assay. Initially, increasing amounts ofMtCMK were added
to the reaction mixture, and measurements of enzymatic reaction
with the nucleotide analogue AraCMP (1 mM) and the substrate
ATP (1 mM) were carried out to determine the range in which the
enzyme activity is linearly dependent on recombinant enzyme con-
centration. The true steady-state kinetic parameters and initial
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zyme activity in the presence of several concentrations of AraCMP
(30–800 lM) against ﬁxed-varying concentrations of ATP (150,
350, 800, 1200 and 2000 lM). The apparent steady-state kinetic
parameters were determined for ddCMP at ﬁxed concentration of
ATP (2 mM) and varying concentrations of the phosphate acceptor
(0.1–50 mM). Data analysis was performed using SigmaPlot 2000
(SPSS, Inc.) software. One unit of MtCMK activity is deﬁned as the
amount of enzyme that catalyzes the formation of 1 lmol of ADP
product per minute. All the measurements were corrected for
non-catalyzed chemical reactions in the absence of MtCMK.
Isothermal titration calorimetry (ITC)
A typical ITC experiment consisted of injections of ligand into
protein, with both solutions in the same buffer. The reference cell
(200 lL) was loaded with Milli Q water and the sample cell
(200 lL) was ﬁlled with MtCMK. A total of either 18 or 25 injec-
tions, each of 2.2 lL or 1.62 lL volume injections, respectively,
were carried out with 5 s duration, at 180 s intervals. An initial
pre-injection of 0.5 lL was made and the result from this injection
was not used for data analysis. The amount of power required to
maintain the reaction cell at constant temperature after each injec-
tion was monitored as a function of time. To correct for the heat
effects not directly related to the binding reaction (heat of dilution
and mixing), control experiments were performed by making iden-
tical injections of the titrant solution into buffer. The control titra-
tions were subtracted from the experimental titrations prior to
data analysis. The stirring speed was 500 rpm at a constant pres-
sure and the enzyme was prepared for ITC experiments by dialysis
against the desired buffer at 4 C.
To determine the order of addition of substrates and release of
products, equilibrium binding values for binary complex formation
were measured by ITC, determining the heat transferred upon li-
gand binding to MtCMK in 50 mM Hepes pH 7.5, 50 mM KCl and
5 mM MgCl2 at 25 C. The sample cell contained MtCMK at 115–
140 lM concentration range and the injection syringe contained
substrates or products at the following concentrations: 4 mM
CMP, 2.5 mM ATP, 4 mM CDP, and 2.5 mM ADP.
To assess whether there is any proton exchange between buffer
and MtCMK:ligand binary complex formation (proton linkage),
binding experiments were carried out at various pH values at
25 C (298.15 K) in buffers with different enthalpies of ionization
(DHion). Buffers and their ionization enthalpies at 25 C were as
follows: Carbonate (2.1 kcal mol1), MES (3.58 kcal mol1),
Hepes (4.94 kcal mol1), MOPS (5.0 kcal mol1), HEPPS
(5.06 kcal mol1), Bis-Tris (6.75 kcal mol1), Imidazol
(8.7 kcal mol1), Ches (9.45 kcal mol1), Tris (10.32 kcal mol1)
and Glycine (10.45 kcal mol1) [23]. All buffers were at 40 mM con-
centration, and contained 40 mMKCl and 5 mMMgCl2. Calorimetric
data on binary complex formation as a function of enthalpy of ion-
ization of buffer were collected with 140 lMMtCMK in the sample
cell, and syringe concentrations were 4 mM for CMP, 3 mM for
dCMP, and 2 mM for AraCMP. Control titrations were performed
to subtract the heats of dilution and mixing for each experiment.
Sequence alignment
Amino acid sequence alignment was performed using the MEGA
software version 4 [24] to identify the residues that are likely to
play a role in nucleotide substrate binding. The amino acid se-
quence of CMK from M. tuberculosis H37Rv (NP_216228.1) was
aligned to the amino acid sequences of ‘‘short’’ human form
UMP/CMP kinase (SP_P30085) and to E. coli CMK (EcCMK) (GB_
ABJ00327.1), whose three-dimensional structures have been
solved [13,18,25,26].Molecular modeling
The homology modeling approach, implemented in the MODEL-
LER [27] 9v10 program, was used to build the models for MtCMK
associated with CMP, dCMP and AraCMP, and E. coli CMK was em-
ployed as template (PDB ID: 1KDO, 1KDR and 1KDP). The protocol
used in the modeling experiments generated 10 models for each
MtCMK:ligand complex. All models were submitted to the DOPE
[28] energy scoring function that is implemented in the MODELLER
9v10 aiming to select the best structures. The MOLPROBITY web-
server [29] and PROCHECK [30] were employed to verify and vali-
date the stereochemical quality of the models. Intermolecular
hydrogen bonds were calculated and displayed with the program
LIGPLOT [31].
Data analysis
The kinetic and binding parameters, as well as their standard
errors were obtained from data ﬁtting to appropriate equations
by using the nonlinear regression function of SigmaPlot 2000
(SPSS, Inc.). Initial rate data at a single concentration of the ﬁxed
substrate were ﬁtted to the Michaelis–Menten equation (Eq. (1))
[32], in which v is the initial velocity, V is the apparent maximum
initial velocity, A is the varying substrate concentration and K rep-
resents the apparent Michaelis–Menten constant.
v ¼ VA
K þ A ð1Þ
The family of lines intersecting to the left of the y-axis in
double-reciprocal plots was ﬁtted to Eq. (2), which describes a
mechanism involving ternary complex formation and a sequential
substrate binding [32].
v ¼ VmaxAB
KiaKb þ KaBþ KbAþ AB ð2Þ
For Eq. (2), v is the initial velocity (as for Eq. (1)), Vmax is the true
maximum initial velocity, A and B are the concentrations of the
substrates, Ka and Kb are their respective Michaelis–Menten con-
stants, and Kia is the dissociation constant for enzyme-substrate
A binary complex formation.
The equilibrium binding constants (Keq), the observed enthalpy
change (DH0obs), and stoichiometry (N) of the formation of the
complex were determined by ﬁtting the binding isotherms to the
standard Marquardt non-linear regression method provided in
the Origin 7 SR4 software (Microcal, Inc.). The overall binding iso-
therms were best ﬁtted to a model of one set of sites. To obtain the
magnitudes of Gibbs free energy (DG0) and the entropy changes
(DS0), the ITC data were ﬁtted to the thermodynamic relationship
described in Eq. (3) [33], in which R is the gas constant
(1.98 cal K1 mol1 or 8.314 J K1 mol1) and T is the temperature
in Kelvin (T = C + 273.15).
DG0 ¼ RT lnKeq ¼ DH0  TDS0 ð3Þ
The number of protonation events occurring upon complex
formation was determined by plotting the observed enthalpy val-
ues ðDH0obsÞ from titration experiments at constant pH in multiple
buffers against the enthalpy of ionization of each buffer ðDHionÞ,
and ﬁtting the data to Eq. (4). The slope of this linear function
is equal to the number of protons released (DnHþ < 0) or taken
up (DnHþ > 0) by the buffer on protein: ligand binary complex
formation, and the y-intercept gives the enthalpy (DH0bind) of bind-
ing that would be measured in a buffer with DHion equal to zero
[34].
DH0obs ¼ DH0bind þ DnHþDHion ð4Þ
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py of ionization equal to zero (DH0bind) contains contributions from
protonation, and thereby does not correspond to the intrinsic bind-
ing enthalpy (DH0int). An estimate for the value of DH
0
int can be de-
rived from ﬁtting the data to Eq. (5) [34,35]:
DH0bind ¼ DH0int þ DnHþDHfp þ HcdDHp ð5Þ
The terms of the above equation are as follows: DHfp is the en-
thalpy of protonation of free protein, Hc corresponds to the frac-
tional saturation of protons in the protein in complex with ligand
(given by Eq. (6)), and dDHp represents the change in enthalpy of
protonation of free protein that occurs upon binding of the ligand.
For Eq. (6), Kcp represents the proton afﬁnity constant for the
liganded form of enzyme.
Hc ¼ K
c
pð10p
H Þ
1þ Kcpð10p
H Þ
ð6Þ
The pKa for the amino acid side chain involved in proton linkage
(proton exchange) upon binary complex formation can thus be
estimated from determination of DnHþ values at different pHs
[34,35]. The observed ligand binding constant (Kobs) at any proton
activity (aHþ = 10
pH) is given by Eq. (7), in which Kint represents
the intrinsic ligand binding constant (the binding constant for
the unprotonated protein), 10pK
cp represents Kcp (proton afﬁnity
constant for the liganded form of enzyme), and 10pK
f c represents
the proton afﬁnity constant for the free form of enzyme (Kfp) [34].
Kobs ¼ K int
1þ 10ðpkcp  pHÞ
1þ 10ðpkfp  pH
Þ
 !
ð7Þ
Eq. (8) (obtained by combining Eqs. (4) and (5)) gives a three-
dimensional surface relating DH0obs to pH and DHion [34].
DH0obx ¼ DH0int þ DnHþDHfp þ HcdDHp þ DnH þ DHion ð8Þ
Results and discussion
Substrate speciﬁcity parameters
Although it has been shown that MtCMK preferentially phos-
phorylates dCMP and CMP [11], further studies to evaluate the en-
zyme speciﬁcity appeared to be warranted to assess the role, if any,
of 30-OH (ddCMP) and stereochemistry of 20-OH groups of the
pentose. Accordingly, to evaluate whether or not a D-arabinose-
containing phosphoryl group acceptor could act as a substrate for
MtCMK enzyme, steady-state kinetic measurements were carried
out with AraCMP as substrate. However, before embarking on
determination steady-state kinetic parameters, experimental con-
ditions for initial velocity measurements should be established.
The activity of MtCMK in the presence of AraCMP and ATP sub-
strates was linearly dependent (linear correlation coefﬁ-
cient = 0.997543; p < 0.0001) on protein concentration in the
reaction mixture (data not shown), thereby showing that true ini-
tial velocities are being measured in this protein concentration
range. Accordingly, steady-state kinetics measurements were car-
ried out in assay mixtures containing 50 nM of recombinant
MtCMK. All initial velocity measurements were carried out in
duplicates. The double-reciprocal plots for the dependence of en-
zyme velocity on varying AraCMP concentrations at ﬁxed-varied
ATP concentrations, and varying ATP concentrations at ﬁxed-var-
ied AraCMP concentrations showed a pattern of intersecting lines
to the left of the y-axis (Fig. 2). These data are consistent with ter-
nary complex formation and suggest a sequential mechanism. In
addition, this pattern of lines rules out ping–pong (parallel lines),steady-state random (that gives non-linear reciprocal plots), and
rapid-equilibrium ordered (one of the family of lines should cross
at a single value on the y-axis) mechanisms. However, the
double-reciprocal plots alone cannot distinguish between rapid-
equilibrium random and steady-state compulsory ordered bi bi
mechanisms. A sequential mechanism is used to denote systems
in which all substrates must bind to the enzyme before any prod-
uct is released. In the rapid-equilibrium random mechanism, any
substrate can bind to free enzyme on route to ternary complex
formation, and all steps that precede the rate-limiting catalytic
step are at equilibrium. In a steady-state compulsory ordered
mechanism, the ternary complex is formed following an ordered
substrate addition, and the rate constants of the binding events
are of the same order of magnitude as the rate constant for the
chemical conversion of substrates into products. The double-
reciprocal data were ﬁtted to the equation for a sequential initial
velocity pattern (Eq. (2)), yielding the following values for the true
steady-state kinetic parameters (linear correlation coefﬁ-
cient = 0.9885; p < 0.0001): kcat = 3.8 (±0.1) s1, KAraCMP = 106
(±6) lM, kcat/KAraCMP = 0.36 (±0.02)  105 M1 s1, KATP = 402
(±25) lM, and kcat/KATP = 9.5 (±0.6)  103 M1 s1. Interestingly,
no enzyme activity could be detected with up to 50 mM of ddCMP
as phosphoryl group acceptor in the presence of 2 mM ATP.
Enzyme mechanism assessed by equilibrium binding of substrates and
products
We have previously reported that the double-reciprocal plots
for the dependence of enzyme velocity on varying CMP concentra-
tions at ﬁxed–varied ATP concentrations, and varying ATP concen-
trations at ﬁxed–varied CMP concentrations showed a pattern of
intersecting lines to the left of the y-axis [11]. However, as re-
ported here for AraCMP, these data could not distinguish between
rapid-equilibrium random and steady-state compulsory ordered bi
bi mechanisms. Accordingly, equilibrium binding constants for
binary complex formation between MtCMK and either substrates
(CMP and ATP) or products (CDP and ADP) were determined by
ITC to determine the enzyme mechanism followed by MtCMK. It
is important to point out that CMP was here employed as a surro-
gate for the alternative phosphoryl group acceptors (dCMP, UMP,
and AraCMP), as MtCMK shows a slight preference to phosphory-
late CMP [11]. The binding reactions were characterized by exo-
thermic heat changes (top panels of Fig. 3) of binding of CMP
(Fig. 3A), ATP (Fig. 3B), CDP (Fig. 3C) and ADP (Fig. 3D) to MtCMK.
The enthalpy of binding for each injection (calculated as the indi-
vidual heat of binding upon integration and normalization of raw
data, corrected for the heat of ligand dilution, and divided by the
number of moles injected) are shown in the bottom panels of
Fig. 3. The ITC data were best ﬁtted to one binding site model, con-
sistent with MtCMK being a monomer in solution [11]. The ITC re-
sults suggest that CMP (Fig. 3A) and ATP (Fig. 3B) substrates can
bind to free MtCMK enzyme. The thermodynamic parameters
(Table 1) for CMP were Kd = 58 (±6) lM, DH0obs = 6.9 (±0.6)
kcal mol1, DG0obs = 5.7 (±0.6) kcal mol1, and TDS0obs = + 1.2
(±0.1) kcal mol1. For ATP, the thermodynamic parameters (Table
1) were Kd = 266 (±16) lM, DH0obs = 4.6 (±0.1) kcal mol1, DG0obs =
4.9 (±0.3) kcal mol1, and TDS0obs = 0.29 (±0.02) kcal mol1. As
the pattern of intersecting lines to the left of the y-axis suggested
either rapid-equilibrium random mechanism or steady-state com-
pulsory ordered mechanism, the ITC data provide support for the
random mechanism of substrate binding to MtCMK (Fig. 4). Inci-
dentally, it has been put forward that the mere demonstration that
both substrates can bind to the free enzyme points towards a ran-
dom-order mechanism [36]. The ITC titrations also suggest that the
product CDP can bind to free enzyme (Fig. 3C), with the following
Fig. 2. Intersecting initial velocity patterns for varied concentrations of AraCMP (A) against ﬁxed–varied concentrations of ATP, and for varied concentrations of ATP (B)
against ﬁxed varied concentrations of AraCMP. The data were ﬁtted to Eq. (2).
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12.8 (±0.5) kcal mol1, DG0obs = 5.8 (±0.9) kcal mol1, and
TDS0obs = +7 (±1) kcal mol1. No titration of ADP binding to free
MtCMK enzyme could be observed by ITC (Fig. 3D), even though
small heat signals corresponding to nonspeciﬁc heat effects were
apparent. As there is a limit of 1 mM for measurable dissociation
constant values by ITC titrations [33], it is possible that ADP binds
to free enzyme with a dissociation constant larger than 1 mM. Not-
withstanding, these data suggest that MtCMK follows an ordered
product release mechanism, in which ADP is released ﬁrst followed
by CDP dissociation from MtCMK:CDP binary complex to yield free
enzyme (Fig. 4). It should, however, be pointed out that this order
of substrate binding and product release is suggested on the basis
of thermodynamic and not kinetic results. Interestingly, a sequen-
tial ordered mechanism for addition of substrates and release of
products has been proposed for E. coli CMK enzyme [26]. As will
be discussed in more detail in Section 3.4, ITC measurements of
dCMP binding to MtCMK (Table 2) yielded dissociation constant
values that were in the same range as for CMP at 25 C (Table 1).
Thermodynamic signatures of substrate(s) and product(s) interactions
The heat changes brought about by protein–ligand complex for-
mation provide thermodynamic signatures of non-covalent inter-
actions to each binding process. Observed enthalpies arise largely
as a result of changes in interatomic interactions (e.g., hydrogen
bonds and/or van der Waals interactions), in which the sign indi-
cates whether there is a net favorable (negativeDH) or unfavorable
(positive DH) redistribution of the network of interactions be-
tween the reacting species (including solvent) [33]. Hydrophobic
interactions are related to the relative degrees of disorder in the
free and bound systems and thus these interactions are reﬂected
in the entropy change. The release of ‘‘bound’’ water molecules
from a surface to the bulk solvent is usually a source of favorable
entropy (positive DS). A reduction in conformational states in
either ligand or protein upon complex formation is entropically
unfavorable (negative DS) [33].
CMP and CDP binding processes to free MtCMK were
characterized by favorable binding enthalpy, unfavorable entropic
contribution, and similar dissociation constant values (Table 1).
The unfavorable entropic contribution for CMP binding process is
likely due to large motions of NMP domain that occurs on MtCMK:
CMP binary complex formation [37]. The larger unfavorable
entropy for CDP may indicate protein conformational changes that
restrict the protein to a particular conformer to facilitate product re-
lease fromMtCMK: CDP binary complex to yield free enzyme,which
is compensated for by the larger enthalpic contribution probably
due to an extra phosphoryl group of CDP as compared to CMP.The ITC data for ATP binding to MtCMK indicate that this pro-
cess is accompanied by favorable enthalpy and entropy changes
(Table 1). The slightly favorable entropic contribution is somewhat
surprising as it has been reported that ATP binding induces confor-
mational changes in the LID domain of CMKs [14,17]. It is thus
tempting to suggest that the favorable overall entropic contribu-
tion is due to exclusion of water molecules fromMtCMK active site,
which should minimize the more favorable intramolecular
hydrolysis of ATP to bound ADP and phosphate in the enzyme ac-
tive site as compared to hydrolysis in solution [38].CMP, dCMP and AraCMP binding proﬁles at 25 C
Comparisons of the binding energetics at 25 C of both natural
substrates suggest that the 20-OH of the pentose plays a minor, if
any, role in binary complex formation (Table 2), as there appears
to be no obvious trend when comparing the values for the overall
dissociation constants (Kd) in different buffers at the same pH
value. The observed enthalpy change values (DH0obs) appear to be
more favorable for CMP as compared to dCMP (Table 2). This could
tentatively be attributed to interactions between the 20-OH of
CMP and MtCMK, which would be absent in the MtCMK:dCMP
binary complex. On the other hand, there appears to be a enthal-
py–entropy compensation as the entropic contribution to
MtCMK:dCMP binary complex formation is somewhat more
favorable as compared to MtCMK:CMP formation. It has been put
forward that the Michaelis–Menten constants for each substrate
(at inﬁnite concentration of the other substrate) in a rapid-equilib-
rium random-order mechanism is equal to the dissociation
constant for dissociation of the substrate from the ternary complex
[36]. The similar values for the Michaelis–Menten constants for
CMP (120 lM) and dCMP (165 lM) previously presented [11] are
in agreement with the ITC data for MtCMK:phosphoryl group
acceptor binary complex formation here reported. However, this
conclusion should be taken with caution as it is known that the
Michaelis–Menten constant represents an apparent dissociation
constant of all enzyme-bound species [39] and it has contribution
from the van Slyke–Cullen constant [40].
It has been shown that there were two molecules in the asym-
metric unit of the crystal structure of E. coli CMK in complex with
dCMP [13]. In one of the crystal structure of E. coli CMK in complex
with dCMP the sugar puckering of the pentose was in C30-endo as
for the binary complex with CMP, whereas it was C20-endo as for
the binary complex with CDP [13]. The C30-endo conformation pre-
ferred for bound CMP brings the 30-OH closer to Arg181 and
Asp185 in E. coli CMK [13], which allows a bidentate interaction
of the carboxylate of Asp185 with both hydroxyls of the ribose.
These authors have proposed that Asp185 of E. coli CMK (Asp187
Fig. 3. Isothermal titration calorimetry (ITC) analysis of binding of ligands. The top panels show the differential power signals (exothermic heat changes) of binding of CMP
(A), ATP (B), CDP (C) or ADP (D) to MtCMK. The bottom panels show the integrated heat pulses, normalized per mol of injectant as a function of the molar ratio (ligand/
MtCMK). The concentrations of protein in the sample cell and ligand in the injection syringe were: (A) CMP: 0.14/4 mM, (B) ATP: 0.125/2.5 mM, (C) CDP: 0.125/4 mM, (D) ADP
0.115/2.5 mM. The normalized binding curves were best ﬁtted to a single set of sites model equation.
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tion-state stabilization), which would involve the interaction of
this residue with the 30-OH favoring a C30-endo conformation,
allowing the 30-OH to interact with Arg181, a residue that can sta-
bilize the a-phosphate of acceptor substrate [13]. These authors
have also proposed that the two alternative modes of binding ofdCMP to E. coli CMK correspond to tight binding (C30-endo as for
E. coli CMK:CMP binary complex) and loose binding (C20-endo as
E. coli CMK:CDP binary complex [13]. The larger Michaelis–Menten
constant value for dCMP as compared to CMP was invoked to sup-
port this hypothesis [13]. However, it does not appear to hold for
MtCMK as the dissociation constant value forMtCMK:dCMP binary
Table 1
Thermodynamic parameters for binary complex formation upon binding of either CMP, ATP, or CDP to MtCMK. Kd represents the equilibrium dissociation constant, DH
0
obs is the
observed binding enthalpy, DS0obs is the observed binding entropy, DG
0
obs is the observed Free Gibbs energy, and TDS0obs is the negative term for temperature (in Kelvin) times
observed binding entropy.
Ligand⁄ Kd (lM) DG0obs (kcal mol
1) DH0obs (kcal mol
1) TDS0obs (kcal mol1)
CMP 58 (±6) 5.7 (±0.6) 6.9 (±0.6) 1.2 (±0.1)
ATP 266 (±16) 4.9 (±0.3) 4.6 (±0.1) 0.29 (±0.02)
CDP 44 (±7) 5.8 (±0.9) 12.8 (±0.5) 7 (±1)
Fig. 4. Proposed enzyme mechanism forMtCMK. Steady-state kinetic and ITC data suggest thatMtCMK follows a mechanism of random order of substrate addition (CMP and
ATP), and an ordered mechanism of product release, in which ADP release is followed by CDP to yield free enzyme.
Table 2
Thermodynamic parameters of NMP (CMP, dCMP, AraCMP) binding to MtCMK at different pH values.
pH Buffer DHion (kcal mol1) DH0obs (kcal mol
1) DG0obs (kcal mol
1) TDS0obs (kcal mol1) Kd (lM)
CMP
6.2 MOPS 5.0 10.55 (±0.07) 5.7 (±0.1) 4.9 (±0.1) 65 (±1)
6.2 Bis-Tris 6.75 9.86 (±0.01) 4.9 (±0.5) 4.9 (±0.5) 234 (±22)
6.2 Imidazol 8.7 8.9 (±0.1) 5.4 (±0.2) 3.6 (±0.2) 115 (±4)
7.6 Hepes 4.94 9.3 (±0.2) 5.6 (±0.5) 3.7 (±0.3) 81 (±7)
7.6 Imidazol 8.7 6.04 (±0.02) 6.2 (±0.7) 0.12 (±0.01) 30 (±3)
7.6 Tris–HCl 10.32 5.6 (±0.2) 6.0 (±0.7) 0.46 (±0.05) 41 (±5)
9.0 Carbonate 2.1 7.03 (±0.09) 5.3 (±0.2) 1.73 (±0.05) 127 (±4)
9.0 HEPPS 5.06 9.5 (±0.2) 5.4 (±0.3) 4.0 (±0.2) 101 (±6)
9.0 Glycine 10.45 11.2 (±0.5) 5.5 (±0.3) 5.7 (±0.3) 91 (±5)
dCMP
6.2 MOPS 5.0 6.6 (±0.1) 5.8 (±0.4) 0.85 (±0.05) 57 (±4)
6.2 Bis-Tris 6.75 5.64 (±0.07) 5.2 (±0.1) 0.49 (±0.01) 167 (±5)
6.2 Imidazol 8.7 4.5 (±0.2) 5.3 (±0.4) 1.1(±0.1) 65 (±6)
7.6 Hepes 4.94 6.7 (±0.1) 5.6(±0.1) 1.14 (±0.02) 72 (±2)
7.6 Imidazol 8.7 6.72 (±0.05) 5.4 (±0.1) 1.29 (±0.02) 104 (±2)
9.0 HEPPS 5.06 8.14 (±0.06) 5.5 (±0.1) 2.65 (±0.06) 94 (±2)
9.0 Ches 9.45 7.28 (±0.09) 5.5 (±0.2) 1.75 (±0.06) 88 (±3)
9.0 Glycine 10.45 7.10 (±0.07) 5.9 (±0.2) 1.22 (±0.04) 50 (±2)
AraCMP
6.2 Mes 3.58 11.6 (±0.3) 6.0 (±0.6) 5.6 (±0.6) 39 (±4)
6.2 MOPS 5.0 5.6 (±0.5) 5 (±2) 0.7 (±0.3) 22 (±9)
6.2 Imidazol 8.7 3.6 (±0.3) 7 (±4) 3 (±2) 13 (±8)
7.6 Hepes 4.94 5.1 (±0.4) 6 (±2) 1.1 (±0.4) 29 (±10)
7.6 Imidazol 8.7 3.6 (±0.4) 6 (±4) 3 (±2) 196 (±130)
9.0 Carbonate 2.1 5.6 (±0.3) 5.4 (±0.3) 0.25 (±0.01) 111 (±7)
9.0 Ches 9.45 7.3 (±0.4) 6 (±2) 1.0 (±0.3) 26 (±7)
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formation (81 lM) in Hepes buffer at pH 7.6 (Table 2). The molec-
ular models for the binary complexes between MtCMK and CMP,
(Fig. 7A), dCMP (Fig. 7B) and AraCMP (Fig. 7C) a C30-endo sugar
puckering for the ribose moiety of these phosphoryl group
acceptors. At any rate, ideally, determination of the crystal struc-
tures for the binary complexes ofMtCMK with either CMP or dCMP
should shed light on this issue.
The effect of stereochemistry of aldopentose sugars was evalu-
ated by comparing the thermodynamics of binary complex forma-
tion between MtCMK and the epimers D-arabinose of AraCMP and
D-ribose of CMP as phosphoryl group acceptors. There appears to
be a reduction in the observed enthalpy changes (DH0obs) for AraC-
MP as compared to CMP (Table 2). However, enthalpy–entropycompensation appears to occur for MtCMK:AraCMP complex for-
mation. In agreement, the Michaelis–Menten constant values for
AraCMP (106 lM) presented here, and CMP (120 lM) and dCMP
(165 lM) reported elsewhere [11] are quite similar, providing the
assumption described at the bottom of the ﬁrst paragraph of this
section is accepted. These observations suggest that the values
for the overall dissociation constant of all enzyme-bound species
for AraCMP, CMP and dCMP are similar. On the other hand, the cat-
alytic constant values for AraCMP (kcat = 3.8 s1) here presented,
and for CMP (kcat = 52 s1) and dCMP (kcat = 30 s1) previously
determined [11] suggest a likely role for the stereochemistry of
20-OH group of the pentose in catalysis. Although we have not
determined the thermodynamic parameters for ddCMP binding
to MtCMK, no enzyme activity could be detected with this phos-
Fig. 6. Alignment of the amino acid sequence of MtCMK (Mt) with E. coli CMK (Ec), for which crystal structures are available, and ‘‘short’’ human UMP/CMP kinase (Hu).
Numbering is indicated for MtCMK. Identical conserved residues are shown in white on a black background. The symbols above the alignment indicate: (d) residues in the
proposed lipophilic part of NMP binding pocket, (.) likely amino acid residues that interact with the pyrimidine ring of CMP/dCMP, (j) likely amino acid residues that
interact with a-phosphate of the CMP/dCMP, () amino acid residue that probably interacts with hydroxyl groups of the pentose. The positions of the phosphate-binding loop
(P loop), the NMPbind domain and the LID domain of the MtCMK are indicated below the alignment.
Fig. 5. Observed binding enthalpy (DHobs) plotted against enthalpy of ionization of buffers (DHion) at pH values of pH 6.2 (d), 7.6 (.), and 9.0 (j), for CMP (A), dCMP (B) and
AraCMP (C). The buffers and their ionization enthalpies (DHion) are given in Table 2. The data were ﬁtted to Eq. (4), in which the slopes provide the number of protons taken
up by the protein (DnHþ > 0) or released to bulk solvent (DnHþ < 0) upon binary complex formation, and the y-intercepts give the enthalpy (DH
0
bind) of binding that would be
measured in a buffer with DHion equal to zero.
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in binding and/or catalysis for the 30-OH group of the pentose.
Interestingly, UMP, CMP and AraCMP have been shown to be bettersubstrates than dCMP for human UMP/CMP kinase, whereas
ddCMP was a poorer substrate (relative efﬁciency of 20%) than
dCMP [41].
Fig. 7. Structural models for MtCMK. (A) MtCMK:CMP. (B) MtCMK:dCMP. (C) MtCMK:AraCMP. The secondary structures are drawn as ribbon diagrams and the residues
making contact with CMP, dCMP and AraCMP are drawn as sticks. Image generated with PyMOL [50].
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To examine the contribution of linked protonation events to the
observed energetics for MtCMK:phosphoryl group acceptor, ITC
experiments were performed at 25 C in buffers with varying
ionization enthalpies at pH values of 6.2, 7.6 and 9.0 (Fig. 5 and Ta-
ble 2). Protonation events linked to nucleotide binding were used
to assess the NMP interaction dependence over a pH range to iden-
tify the energetics of binding and a possible pKa shift upon binary
complex formation. The number of protons taken up by the protein
(DnHþ > 0), or released to bulk solvent (DnHþ < 0), upon nucleotide
binding and the DH0bind were determined based on the relationship
given by Eq. (4). The dependence of DH0obs on DHion at pH values of
6.2, 7.6 and 9.0 upon binary complex formation are depicted in
Fig. 5. Data ﬁtting to Eq. (4), yielded the number of protons ex-
changed (DnHþ ) upon binary complex formation at pH values of
6.2, 7.6 and 9.0 that were, respectively: 0.43, 0.73 and 0.47 for
MtCMK:CMP; 0.57, 0.018 and 0.19 for MtCMK:dCMP; and 1.57,
0.4 and 0.22 forMtCMK:AraCMP. These results suggest a net gain
of protons upon binary complex formation at pH values near phys-
iological. Primary sequence comparison (Fig. 6), and analysis of
MtCMK structural model (Fig. 7) and of other bacterial CMK protein
structures [13,14,42] suggest that the chemical groups that may
contribute to the proton uptake effect include the 3-imino group
of pyrimidine ring (pKa of 4.26), and/or the side chain(s) of
Asp134 and Asp187 (Fig. 7) located in the NMP binding site (pKa
value of 3.9–4.0 for the b-carboxyl group of aspartate in solution).
It is possible that this protonation event would assist in orientating
the hydroxyl group of a-phosphate of the phosphoryl group accep-
tor (CMP, dCMP or AraCMP) ready for nucleophilic attack by the c-
phosphate of ATP. Incidentally, it has been shown that Asp185 of
E. coli CMK (corresponding to Asp187 in MtCMK) plays a more rel-
evant role in catalysis than in NMP substrate binding [13]. It has
also been pointed out that whether the a-phosphate of the sub-
strate acceptor (e.g., CMP) is protonated in phosphoryl transfer
reactions remains controversial as the local enzymatic environ-
ment can inﬂuence its pKa value [43,44]. Quantum mechanics cal-
culations have suggested that UMP/CMP kinase from Dictyostelium
discoideum follows a concerted phosphoryl transfer mechanism in
which the a-phosphate group of CMP is protonated [45]. Accord-
ingly, it is plausible that Asp185 (corresponding to Asp187 in
MtCMK; Fig. 7) is the likely candidate for the protonation event
as it has been shown to interact with the pentose whereas
Asp132 (corresponding to Asp134 in MtCMK) forms H-bonds toTable 3
Thermodynamic parameters derived from Eqs. (5)–(7).
Ligand Kint (lM) pKacoupled DH0int (k
CMP 114.6 5.5 (±0.5) 8.7 (±
dCMP 76.42 5.6 (±0.1) 7.96 (
AraCMP 13.34 6.1 (±0.1) 3.57 (cytosine bound to E. coli CMK [13]. Site-directed mutagenesis of
Asp134 and Asp187 residues of MtCMK should, however, be pur-
sued in the near future to provide a solid ground to this proposal.
The lack of a common crossing point at the y-axis intercepts of
the linear functions of Fig. 5 demonstrates that the values for DH0bind
change as a function of pH. Accordingly, there exists a change in
enthalpy of protonation of free protein that occurs upon binding
of the ligand, that is, there is a dDHp term and thereby DH
0
bind does
not correspond to the intrinsic binding enthalpy (DH0int) at all pH
values [34]. Data ﬁtting of DH0bind values (Table 2) to Eq. (5) yielded
estimates for the intrinsic binding enthalpy (DH0int), the enthalpy of
protonation of free protein (DHfp), the fractional saturation of pro-
tons in the protein in complex with ligand (Hc), and the change in
enthalpy of protonation of free protein that occurs upon binding of
the ligand (dDHp). In other words, for the latter, DH
c
p = DH
f
p + dDHp.
Data ﬁtting to Eqs. (6) and (7) yielded values for both the proton
afﬁnity constant for the form of enzyme in complex (Kcp), and
thereby its pKa value and the intrinsic ligand binding constant for
unprotonated protein (Kint). These results are given in Table 3.
Alternatively, global ﬁtting to Eq. (8) of experimental DH0obs values
as a function of pH and DHion allows a three-dimensional represen-
tation of data, as shown in the graphical abstract. The latter pro-
vides a summary of the data given in Fig. 5 and Table 2.
The calculated pKa coupled for CMP, dCMP and AraCMP using
aspartate as a possible source of the protonation event were,
respectively, 5.5, 5.6 and 6.1 (Table 3). These values suggest similar
changes in pKa values for the natural substrates, and a larger
change for the synthetic AraCMP substrate. The lower intrinsic li-
gand binding afﬁnity value for AraCMP suggests that its interaction
with unprotonated MtCMK is less favorable as compared to CMP
and dCMP (Table 3), which are likely the physiological substrates.
The exothermic intrinsic binding enthalpies are twofold more
favorable for CMP and dCMP as compared to AraCMP, thereby indi-
cating a more pronounced role for entropy in AraCMP binding over
the pH range studied here as its Kint value is lower as compared to
the natural substrates.
Baker and Murphy [34] have pointed out that in case dDHp is
equal to, or close to, zero, plots of DH0obs versus DHion at any pH
would all intersect where DHion is equal to and opposite the pro-
tonation enthalpy of free protein (DHfp = DHion). Measurements
carried out at pH 6.2 and 7.6 for CMP and dCMP demonstrate a
common intercept at DHion close to 0, indicating a low ionization
enthalpy. As carboxylate groups have low DHion values, it is tempt-
ing to suggest participation of either Asp134 or Asp187 in thiscal mol1) DHfp (kcal mol
1) dDHp (kcal mol
1)
215) 8.23 (±315) 2.65 (±214)
±816) 5.81 (±515) 6.86 (±114)
±316) 8.6 (±115) 0.071 (±415)
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other hand, measurements at pH 9.0 for CMP and dCMP and all
measurements carried out with AraCMP show an intersection dis-
tant from DHion value of zero, indicating that another residue with
a larger ionization enthalpy might be involved. As amine-type
groups have large DHion values and carboxylate groups low DHion
values, it is tempting to suggest that a group other than Asp134
and Asp187 is(are) involved in proton linkage events seen at high
pH. The 3-imino group of pyrimidine ring is neutral and any con-
served arginine (Arg111, Arg133, Arg183 and Arg190 in MtCMK)
could be invoked as involved in proton uptake from primary se-
quence comparison data (Fig. 6). On the other hand, structural
analysis of MtCMK suggests that the side chain of Arg42, Arg111,
Arg133, and Arg190, all of which make contact with the phos-
phoryl group acceptor, could play a role in proton uptake. The crys-
tal structure of E. coli CMK show H-bond interactions between
Arg41 and Arg131 with a-phosphate, and between Arg110 and
Arg188 with the cytosine of phosphoryl group acceptor [13]. In
the Staphylococcus aureus CMK crystal structure [42], Arg39 and
Arg126 are H-bonded to the a-phosphate, Arg105 interacts with
both the cytosine moiety and a-phosphate, Arg183 forms H-bonds
to cytosine, and Arg176 interacts with the hydroxyl groups of the
pentose. At any rate, site-directed mutagenesis of Arg111,
Arg133, Arg183 and Arg190 residues of MtCMK should be carried
out to shed light on this proposal.
Sequence alignment and MtCMK structural analysis
The crystallographic structures of E. coli CMP kinase (Protein
Data Bank accession numbers: 1KDO, 1KDP, 1KDR, 1CKE, and
2CMK) [13,18] in complex with substrates or products together
with a three-dimensional model of MtCMK in complex with CMP
[37], Fig. 7 permit to propose the possible amino acid side chains
in MtCMK that are involved in binding of the phosphoryl group
acceptors (CMP, dCMP, AraCMP, ddCMP). A comparison between
bacterial CMKs and human UMP/CMP kinase may assist in identi-
fying the residues responsible for discrimination between CMP
and dCMP over UMP. The amino acid sequence alignment of the
MtCMK and EcCMK reveals that these orthologues share a
sequence identity of 38.7% (Fig. 6). In contrast, the amino acid
sequence of MtCMK is 9.5% identical to human UMP/CMP kinase
(Fig. 6).
The side chains of Arg111, Arg133, Asp134, Arg183, Asp187 and
Arg190 (MtCMK numbering) make contacts with CMP (Fig. 7) and
are conserved in the bacterial CMK proteins (Fig. 6). The larger
speciﬁcity constant of E. coli CMK for CMP (2.9  106 M1 s1)
[13] as compared to MtCMK (0.4  106 M1 s1) [11] is consistent
with increased intermolecular contacts in the former [37]. The
amino acids of E. coli that form H-bonds to cytosine (Asp132,
Arg110 and Arg188), which correspond to Asp134, Arg111 and
Arg190 in MtCMK (Fig. 6), are conserved only in bacterial CMKs
[13]. The structure of E. coli CMK in complex with dCMP is some-
what similar to the structure with CMP except differences in sugar
puckering and in interactions between the pentose and Asp185,
Ser101 and Arg181 residues (Asp187, Ser102 and Arg183 in
MtCMK). There is a 10-fold reduction for AraCMP speciﬁcity con-
stant for MtCMK similar to E. coli CMK [13]. As mentioned above,
no activity could be detected with ddCMP (up to 50 mM) for
MtCMK enzyme in the presence of 2 mM ATP, whereas a 10,000-
fold reduction in speciﬁcity constant was observed for E. coli
CMK [13]. The structures of E. coli CMK in complex with either
AraCMP or ddCMP showed that a few intermolecular interactions
are lost, such as no H-bond between the a-phosphate and
Arg131 and Arg181 residues (Arg133 and Arg183, respectively, in
MtCMK). For AraCMP, a loss of interaction between the 30-OH
group of the pentose and Ser101 (Ser102 in MtCMK) was alsoobserved. For ddCMP, the absence of 30-OH group resulted in loss
of polar interactions between Arg181 (Arg183 in MtCMK) and
between Asp132 (Asp134 in MtCMK) and the nucleobase. Site-
directed mutagenesis studies have shown the role of Asp132 in
substrate recognition for E. coli UMP kinase [25].
It has been pointed out that the Ser36 residue (Thr37 in
MtCMK), which is common to CMP kinases from Gram-negative
bacteria, alternates in CMP kinases from Gram-positive organisms
with a Thr side chain, but never with Ala as in UMP/CMP kinases
[25]. Site-directed mutagenesis has been employed to show that
Arg110 and Ser36 side chains (Arg111 and Thr37 inMtCMK), which
are not conserved in human UMP/CMP kinase (Fig. 6), cannot form
H-bonds with UMP, and their substitutions affect the steady-state
kinetic parameters for CMP and dCMP [25]. The Ser36 residue has
been proposed to act as an H-bond acceptor for the substrates [25].
Based on crystal structure of apo enzyme and molecular modeling,
it has been shown how substrate-induced conformational changes
(open to closed conformations) can be invoked to explain the lar-
ger afﬁnity of human UMP/CMP kinase for UMP and CMP as com-
pared to dCMP and AraCMP, and the role of Lys61 in substrate
discrimination [46].Conclusions
The results presented in our manuscript allowed both a number
of conclusions to be drawn and proposals to be suggested. The D-
arabinose-containing phosphoryl group acceptor (AraCMP) is a
substrate for MtCMK enzyme. The 20-30-dideoxy-cytidine 50-mono-
phosphate (ddCMP) is not a phosphoryl group acceptor of MtCMK.
Steady-state kinetic measurements and ITC data upon binary com-
plex formation suggest that MtCMK follows a random mechanism
for substrate (CMP and ATP) addition, and an ordered mechanism
of product release mechanism, in which ADP is released ﬁrst fol-
lowed by CDP. Thermodynamic signatures of CMP and CDP binding
toMtCMK showed favorable binding enthalpy and unfavorable en-
tropy of binding. ATP binding was characterized by favorable en-
thalpy and entropy changes. The ITC data for CMP, dCMP and
AraCMP binding processes showed similar dissociation constant
values. Based on ITC and steady-state kinetics data, it is proposed
a role in catalysis for the stereochemistry of 20-OH group of the
pentose. No enzyme activity could be detected with ddCMP, sug-
gesting a role in binding and/or catalysis for the 30-OH group of
the pentose. ITC experiments to address the contribution of linked
protonation events to the energetics for MtCMK:phosphoryl group
acceptor binary complex formation indicated that there is a net
gain of protons at pH values near physiological. This result
prompted the proposal that this protonation event assists in orien-
tating the hydroxyl group of a-phosphate of the phosphoryl group
acceptor ready for nucleophilic attack by the c-phosphate of ATP.
In addition, Asp187 of MtCMK is suggested as the likely candidate
for the protonation event. Values of 5.5, 5.6 and 6.1 were calculated
for pKa coupled for, respectively, CMP, dCMP and AraCMP using
aspartate as a possible source of the proton linkage event. A com-
parison of crystallographic structures of E. coli CMP kinase and a
molecular model of MtCMK allowed to identiﬁcation of amino acid
side chains involved in binding of phosphoryl-group acceptor sub-
strate. Residues that are conserved in CMP kinases from prokary-
otes and not conserved in human UMP/CMP kinase are discussed,
and these differences may assist in the design of species-speciﬁc
inhibitors of MtCMK enzyme activity.
The currently available repertoire of antimycobacterial agents
reveals only a handful of comprehensively validated targets,
namely RNA polymerase, DNA gyrase, NADH-dependent enoyl-
ACP reductase and ATP synthase [47]. The target-based rational
design of new agents with anti-TB activity includes functional
L. Jaskulski et al. / Archives of Biochemistry and Biophysics 536 (2013) 53–63 63and structural efforts. Accordingly, mechanistic analysis should be
included in enzyme-targeted drug programs aiming at the rational
design of potent enzyme inhibitors. Moreover, ITC has been used as
an important technique for the direct determination of thermody-
namic parameters of enzymatic reactions [48]. The substrate spec-
iﬁcity ofMtCMK as compared to human UMP/CMP kinase indicates
that the former may represent a possible target for anti-TB drug
development. Understanding the mode of action of MtCMK should
inform us on how to better design inhibitors targeting this enzyme
with potential therapeutic application in TB chemotherapy. Inci-
dentally, the U.S. Food and Drug Administration has recently ap-
proved bedaquiline, an ATP synthase inhibitor, for treatment of
multi-drug resistant strains of M. tuberculosis [49].
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